Gain Therapeutics, Inc. (NASDAQ:GANX) People

Gain Therapeutics, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Charles Evan Ballantyne
Other companies: Agenus Inc. (CFO · Jun 17, 2015 – Jun 14, 2016 · Past); Theriva Biologics, Inc. (Chief Financial Officer · Feb 6, 2012 – Jan 8, 2015 · Past); Clinical Data Inc (EVP, CFO · Jun 14, 2007 – Apr 12, 2011 · Past)
Chief Financial Officer · Apr 10, 2023 – Apr 10, 2023 · Past
Eric I Richman
Other companies: NeuBase Therapeutics Inc (Director · Jul 12, 2019 – Sep 9, 2022 · Past); ADMA Biologics Inc (Director · Nov 9, 2017 – Feb 28, 2020 · Past)
Director · Since at least Mar 17, 2021
Hans Peter Hasler
Other companies: Minerva Neurosciences, Inc (Member · Since at least Dec 10, 2017); Patheon N.V. (Director · Jul 20, 2016 – Aug 29, 2017 · Past)
Director · Since at least Mar 17, 2021
Gene Mack
Other companies: SELLAS Life Sciences Group, Inc. (CFO and Treasurer · Apr 20, 2018 – Apr 20, 2018 · Past)
Chief Executive Officer · Since at least Apr 5, 2024
Jeffrey Riley
Other companies: Theriva Biologics, Inc. (Chief Executive Officer, Director · Mar 16, 2010 – Nov 30, 2016 · Past)
Independent Member · Since at least Mar 17, 2021
Apaar JammuDirector, Investor Relations and Public Relations · Since at least Oct 8, 2026
Claude NicaiseIndependent Member · Since at least Nov 5, 2026
Dov GoldsteinIndependent Member · Since at least Nov 5, 2026
Gianluca FuggettaSee Remark · Since at least Dec 12, 2022
Gwen MelincoffIndependent Member · Since at least Nov 5, 2026
Investors:Gain TherapeuticsInc. Apaar Jammu Director, Investor Relations and Public · Since at least Oct 1, 2026
Khalid IslamChairman · Since at least Nov 5, 2026
Manolo BellottoPresident and General Manager · Mar 17, 2021 – Mar 17, 2021 · Past
Salvatore CalabreseChief Financial Officer · Mar 17, 2021 – Mar 23, 2023 · Past